F099 JAK Inhibitors in Dermatology: Identifying Ideal Candidates
DESCRIPTION
JAK inhibitors have expanded systemic treatment options for atopic dermatitis, alopecia areata, and psoriasis, offering rapid efficacy through a novel mechanism. However, their use requires careful patient selection and risk assessment, considering potential concerns such as infection, thrombosis, malignancy, and lab monitoring. This session will review all FDA-approved systemic JAK inhibitors for dermatologic use, comparing efficacy and safety with other treatments. Attendees will learn to identify ideal candidates, recognize when to avoid JAKs, and apply strategies to mitigate risks. Data from recent research on elderly patients will be included to guide safe prescribing in special populations.
LEARNING OBJECTIVES
Compare the efficacy and safety of JAK inhibitors with other systemic treatment options for AD, AA, and Pso.
Recognize and manage common and rare adverse events associated with JAK inhibitors, including monitoring recommendations.
Apply an evidence-based, patient-centered approach to selecting systemic therapies—particularly JAK inhibitors—by identifying ideal patient subtypes and recognizing populations that require caution, while balancing efficacy, safety, and individual risk factors.
SCHEDULE
3:30 PM
JAKpot! Therapeutic Advantages of JAK Inhibitors in Dermatology: Identifying The Right Patient
Diego Dasilva, MD, FAAD
3:55 PM
MOA, Safety & Systemic Inflammation in JAK Inhibition
Christopher Bunick, PhD, MD, FAAD
4:20 PM
Precision Signaling: How JAK Inhibitors Work and Why It Matters
Mona Shahriari, MD, FAAD
4:45 PM
The Devil Is in the Details: Understanding JAK Trial Populations and Real-World Risk
Eingun James Song, MD, FAAD
5:10 PM
Panel Q&A
DIRECTOR
Diego Dasilva, MD, FAAD
SPEAKERS
Christopher Bunick, PhD, MD, FAAD
Mona Shahriari, MD, FAAD
Eingun James Song, MD, FAAD
DISCLOSURES
Christopher Bunick, PhD, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Advisory Boards - South Beach Symposium – Advisory Board(Fees); Almirall – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Consultant (1099 relationship)(Fees); Daiichi Sankyo – Investigator(Grants/Research Funding); Dermatology Times (MMM MultiMedia Medical, LLC) – Advisory Board(Fees); Dermsquared – Speaker/Faculty Education(Fees); Eli Lilly – Consultant (1099 relationship)(Fees); LEO Pharma, US – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); LiVDerm – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Palvella Therapeutics – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Regeneron – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Teladoc Health, Inc. – Consultant (1099 relationship)(Fees); Timber Pharmaceuticals – Investigator(Grants/Research Funding); UCB – Advisory Board(Honoraria);
Diego Dasilva, MD, FAAD
AbbVie – Speaker/Faculty Education(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Dermavant Sciences, Inc. – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Leo Pharma – Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria); UCB – Speaker(Honoraria); Verrica Pharmaceuticals Inc – Speaker(Honoraria);
Mona Shahriari, MD, FAAD
AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences – Investigator(Grants/Research Funding), Speaker(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); Incyte Corporation – Advisory Board(Honoraria); Janssen Biotech – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); LEO Pharma, US – Consultant(Honoraria), Speaker/Faculty Education(Honoraria); National Psoriasis Foundation – Speaker/Faculty Education(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi/Regeneron – Consultant(Honoraria), Speaker(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);
Eingun James Song, MD, FAAD
AbbVie – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Alphyn Biologics – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding), Speaker(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); BMS – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Fees); Castle Biosciences, Inc – Advisory Board(Honoraria); Dermavant Sciences – Advisory Board(Honoraria); DermBiont – Investigator(Grants/Research Funding); Eli Lilly – Speaker/Faculty Education(Honoraria); Galderma – Speaker(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding), Speaker(Honoraria); Janssen – Investigator(Grants/Research Funding); Janssen Biotech – Speaker(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Novartis – Consultant(Fees); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Timber Pharmaceuticals – Investigator(Grants/Research Funding); UCB – Speaker(Honoraria);